Xeljanz (tofacitinib) approved for treatment of ulcerative colitis
Last updated: 01 November 2019
You can legally access new medicines, even if they are not approved in your country.
Learn more »Moderately to severely active ulcerative colitis can now be treated with tofacitinib following an expanded approval by the FDA.
This will provide a much-needed alternative therapy for a debilitating disease with limited treatment options. To find out about ulcerative colitis and how this medicine works please read the full FDA article.
